About: Amiodarone in the COVID-19 Era: Treatment for Symptomatic Patients Only, or Drug to Prevent Infection?

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Amiodarone in the COVID-19 Era: Treatment for Symptomatic Patients Only, or Drug to Prevent Infection? Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Amiodarone in the COVID-19 Era: Treatment for Symptomatic Patients Only, or Drug to Prevent Infection?
Creator	Lavie, Carl Sanchis-Gomar, Fabian Daniel, · Laukkanen, Jari Carme Perez-Quilis, · Morin, P Perez, Marco
Source	Medline; PMC
abstract	Amiodarone, one of the most widely prescribed antiarrhythmic drugs to treat both ventricular and supraventricular arrhythmias, has been identified as a candidate drug for use against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We present the rationale of using amiodarone in the COVID-19 scenario, as well as whether or not amiodarone administration represents a potential strategy to prevent SARS-CoV-2 infection, rather than simply used to treat patients already symptomatic and/or with severe coronavirus disease 2019 (COVID-19), based on current evidence.
has issue date	2020-08-01(xsd:dateTime)
bibo:doi	10.1007/s40256-020-00429-7
bibo:pmid	32737841
has license	no-cc
sha1sum (hex)	18194ef2effbd094b3cd54276bfe0cb2f0eff8d4
schema:url	https://doi.org/10.1007/s40256-020-00429-7
resource representing a document's title	Amiodarone in the COVID-19 Era: Treatment for Symptomatic Patients Only, or Drug to Prevent Infection?
has PubMed Central identifier	PMC7394926
has PubMed identifier	32737841
schema:publication	Am J Cardiovasc Drugs
resource representing a document's body	covid:18194ef2effbd094b3cd54276bfe0cb2f0eff8d4#body_text
is schema:about of	named entity 'candidate' named entity 'amiodarone' named entity 'PRESCRIBED' named entity 'CURRENT' named entity 'SYMPTOMATIC' named entity 'current' named entity 'ventricular' named entity 'treat' named entity 'potential' named entity 'infection' named entity 'amiodarone' named entity 'SARS-CoV-2' named entity 'amiodarone' named entity 'Amiodarone' named entity 'myeloperoxidase' named entity 'COVID' named entity 'murine' named entity 'amiodarone' named entity 'clinical trials' named entity 'COVID-19' named entity 'amphiphilic' named entity 'MCP-1' named entity 'SARS-CoV-2 virus' named entity 'inflammatory cytokines' named entity 'clinical trials' named entity 'proinflammatory cytokines' named entity 'creatine' named entity 'SARS-CoV-2' named entity 'ischemic cardiomyopathy' named entity 'amiodarone' named entity 'clinical trial' named entity 'myeloperoxidase' named entity 'endocytic' named entity 'myocarditis' named entity 'catalase' named entity 'amiodarone' named entity 'drug administration' named entity 'Ebola virus' named entity 'angiotensin' named entity 'ventricular arrhythmias' named entity 'Amiodarone' named entity 'anti-inflammatory' named entity 'oxidative stress' named entity 'COVID' named entity 'glutathione' named entity 'viral infection' named entity 'all-cause mortality' named entity 'amiodarone' named entity 'disopyramide' named entity 'cardiac myocytes' named entity 'older people' named entity 'amiodarone' named entity 'quinidine' named entity 'bradyarrhythmia' named entity 'combination of drugs' named entity 'amiodarone' named entity 'COVID' named entity 'plasma membrane' named entity 'IL-6' named entity 'pulmonary toxicity' named entity 'ventricular arrhythmias' named entity 'dronedarone' named entity 'encephalomyocarditis virus' named entity 'CRP' named entity 'volume of distribution' named entity 'COVID-19 infection' named entity 'edema' named entity 'antiarrhythmic drugs' named entity 'COVID-19' named entity 'amiodarone' named entity 'amiodarone' named entity 'antiretroviral medications' named entity 'antiarrhythmic drug' named entity 'IL-6' named entity 'treat patients'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software